Stratec SE
XETRA:SBS

Watchlist Manager
Stratec SE Logo
Stratec SE
XETRA:SBS
Watchlist
Price: 30.8 EUR 11.8% Market Closed
Market Cap: 374.4m EUR
Have any thoughts about
Stratec SE?
Write Note

Net Margin
Stratec SE

4%
Current
9%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
4%
=
Net Income
10m
/
Revenue
250.5m

Net Margin Across Competitors

Country DE
Market Cap 374.4m EUR
Net Margin
4%
Country US
Market Cap 208.4B USD
Net Margin
14%
Country US
Market Cap 192.4B USD
Net Margin
29%
Country US
Market Cap 148.5B USD
Net Margin
16%
Country US
Market Cap 133.6B USD
Net Margin
11%
Country IE
Market Cap 111.2B USD
Net Margin
13%
Country US
Market Cap 65.3B USD
Net Margin
9%
Country DE
Market Cap 56.9B EUR
Net Margin
8%
Country CN
Market Cap 326.2B CNY
Net Margin
33%
Country US
Market Cap 42.5B USD
Net Margin
74%
Country US
Market Cap 38B USD
Net Margin
9%
No Stocks Found

Stratec SE
Glance View

Market Cap
374.4m EUR
Industry
Health Care

STRATEC SE engages in the design and manufacture of automated analyzer systems in the fields of clinical diagnostic and biotechnology. The company is headquartered in Birkenfeld, Baden-Wuerttemberg and currently employs 1,398 full-time employees. Its business activities are divided into three segments: Instrumentation, which designs and manufactures fully automated analyzer systems for its clinical diagnostics and biotechnology customers; Diatron, which offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications, and Consumables, which develops and sells scientific materials, such as nucleic acid purification and designs and produces smart consumables in the fields of diagnostics, life sciences, and medical technology. In addition, the Company develops workflow software for networking various analyzer systems, as well as develops and sells scientific materials and technologies.

SBS Intrinsic Value
57.96 EUR
Undervaluation 47%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
4%
=
Net Income
10m
/
Revenue
250.5m
What is the Net Margin of Stratec SE?

Based on Stratec SE's most recent financial statements, the company has Net Margin of 4%.